Navigation Links
LDH Measurement Can Predict Outlook Of Patients With SCD

Individuals, more specifically adults at risk of developing sickle cell disease related complications could be identified by a simple test // that measures the levels of the enzyme lactate dehydrogenase (LDH). Sickle cell disease is a genetic disorder characterized by sickle shaped red blood cells with compromised oxygen carrying capacity.

Kidney, heart, liver and red blood cells are some rich sources of the enzyme, although trace amounts of the enzyme can be found in other cell types. Under diseased conditions, the cells that contain the enzyme release the same, leading to elevated levels of the enzyme in the same.

The researchers analyzed the LDH levels in over 213 adults, diagnosed with sickle cell disease. The study participants were divided into three groups based on their serum LDH level (high, medium, low). Individuals with high LDH levels (512-1171 IU/L) had a higher incidence of disease related complications such as priapism (persistent painful erections), leg ulcerations and pulmonary hypertension. The severity of the complication could be correlated to the LDH level. Furthermore, the survival rate of those with high LDH levels was comparatively lower than the other two groups.

Following these findings, it has been suggested that a measurement of LDH level can be used to determine the progress of the disease and provide an estimate of the associated complication risk. It can even predict which patients will survive longer.

The correlation of the LDH levels and the disease severity was found to be independent of the standard treatment with hydroxyurea. Vaso-occlusive cries, caused due to the sickle shaped RBC’s obstructing the blood vessels, a hallmark of sickle cell disease were also not found to influence LDH levels. The results of this clinically important study can be found in the latest issue of Blood, a journal published by the American Society of Hematology.

'LDH levels illuminate a pattern of pathology in sickle cell disease patients. This study suggests that LDH testing may be a worthwhile addition to 'well adult' visits for individuals with sickle cell anemia, though the significance in children and adolescents, remains unclear. As a result, LDH appears to hold great promise as an effective indicator for identifying patients most at risk and in need of possible preventive care and careful monitoring,' concluded the researchers.


'"/>




Related medicine news :

1. Study On Self Measurement Of Blood Pressure
2. Childhood Obesity Vs Malnutrition- A Spotlight On WHO Obesity Measurement For Kids
3. Virus Level could Predict Cervical Cancer Risk
4. Long-Term Survival can be Predicted by a Simple Lung Test
5. White Cells Count Can Predict Heart Attack Death Risk
6. Predictable genes
7. Restricted Activity Predicts Disability
8. Fitness Level Predicts Stroke
9. Elevated LDL levels in Childhood could be Predictors of Heart Disease
10. Brain Scans Help Predict Alzheimers Disease
11. Predictors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... 2017 , ... Healthful Balance announces the national release of ... by Ed Stroup, was created to offer the highest quality vitamins and supplements ... service. Healthful Balance products can be purchased online through their website, or can ...
(Date:1/17/2017)... ... January 17, 2017 , ... Kevin Harrington (one of ... will be featuring DRTV campaigns regarding the topic of Beauty and Personal Care. ... version of themselves. What better way to commit to these changes than beginning with ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development ... to infusing high speed technology into the fabric of an entire community. A ... of healthcare and wellness in a yet-to-be-named, health focused campus. Leading this initiative ...
(Date:1/17/2017)... TX (PRWEB) , ... January 17, 2017 , ... Mirror ... have earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice ... named part of this elite group of providers. , Produced by Zeltiq, CoolSculpting ...
(Date:1/17/2017)... ... 17, 2017 , ... Peoples Health is pleased to announce ... Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than ... to our provider network, and the addition will benefit our members in the ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
(Date:1/17/2017)... and Markets has announced the addition of the "The Top 200 ... ... profiles the leading 200 manufacturers and distributors of molecular diagnostics products worldwide. ... States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics Companies ...
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
Breaking Medicine Technology: